Laparoscopic oophorectomy either with or without hysterectomy for early breast cancer

European Journal of Gynaecological Oncology

Volumn 28, Issue 4, 2007, Pages 294-296

  Kucera, E ^a   Holub, Z ^b   Svobodova, G ^b  

^a INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^b Baby Friendly Hospital   (Czech Republic)

Author keywords

Breast cancer; Hysterectomy; Laparoscopy; Oophorectomy

Indexed keywords

TAMOXIFEN;

ADENOMYOSIS; ADULT; ARTICLE; BLEEDING; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; CONVERSION DISORDER; CYSTADENOMA; ENDOMETRIUM TUMOR; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LEIOMYOMA; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CANCER; OVARY CYST; TERATOMA; TREATMENT OUTCOME; URETER INJURY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TAMOXIFEN;

EID: 34547808870     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ovarian ablation for early breast cancer. The Cochrane Databases of Systematic Reviews, 2006, Issue 4.h, http:// www.cochrane.org.review.
2. Holub Z., Voracek J., Kliment L., Lukac J.: "Laparoscopic hysterectomy: Randomized study of harmonic scalpel and electrosurgery". J. Gynecol. Surg., 2000, 16, 33.
3. Featherstone C.J., Harrnett A.N., Brunt A.M., Johnson L.: "Methods of ovarian suppression used in the UK". The Breast, 2002, 11, 23.
4. Novotny Z., Rojikova V.: "Complications of laparoscopic-assisted vaginal hysterectomy, a 1996 survey of the Czech Republic". J. Am. Assoc. Gynecol. Laparosc., 1999, 6, 459.
5. Kwon A.H., Yamada O., Uetsuji S., Matsui Y., Kamiyam Y.: "Prophylactic laparoscopic ovarian ablation for premenopausal breast cancer: medical and economic efficacy". Surg. Laparosc. Endosc., 1997, 7, 223.
6. Barakat R.R.: "The effects of tamoxifen on the endometrium". In: Coukos G., Rubin S.C. Cancer of the uterus. New York, Marcel Dekker, 2005.
7. Beiner M.E., Finch A., Rosen B., Lubinski J., Moller P., Ghardirian P. et al.: "The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study". Gynecol. Oncol., 2007, 104, 7.
8. .[8] Lu K.H., Kauft N.D.: "Does a BRCA mutation plus tamoxifen equal hysterectomy". Gynecol. Oncol., 2007, 104, 3.
9. Beral V., Bull D., Reeves G., Million Women Study Collaborators.: "Endometrial cancer and hormone-replacement therapy in the Million Women Study". Lancet, 2005, 365, 1543.